DC
GMED icon

Davenport & Co’s Globus Medical GMED Stock Holding History

Davenport & Co’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,897
Closed -$612K – 1006
2022
Q2 		$612K Buy
10,897
+1,446
+15% +$95K 0.01% 630
2022
Q1 		$697K Buy
9,451
+1,782
+23% +$124K ﹤0.01% 641
2021
Q4 		$554K Sell
7,669
-299
-4% -$21.7K ﹤0.01% 727
2021
Q3 		$611K Buy
+7,968
New +$640K ﹤0.01% 673

Other funds holding GMED

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Davenport & Co's GMED Position: Q3 2022 in Review

Davenport & Co sold out of Globus Medical (GMED) in Q3 2022, closing a stake of 10,897 shares — an estimated $612K sold.

Davenport & Co first reported a position in GMED in Q3 2021 and held it in 4 quarters. The position peaked at $697K in Q1 2022. 370 funds tracked by Wall St. Rank hold GMED as of Q3 2022.

  • Davenport & Co reported no remaining Globus Medical position as of Q3 2022 after selling out during the quarter.
  • Davenport & Co sold 10,897 Globus Medical shares in Q3 2022, an estimated $612K.
  • Davenport & Co first reported a position in Globus Medical in Q3 2021 and held it in 4 quarters.
  • Davenport & Co's Globus Medical position peaked at $697K in Q1 2022.
  • 370 funds tracked by Wall St. Rank held Globus Medical as of Q3 2022.

Based on Davenport & Co's 13F filing for Q3 2022, filed 11 Oct 2022.